Canadian province warns of high cost of "interoperable" PACS:
This article was originally published in Clinica
Executive Summary
The cost of making differing e-health systems interoperable is one of the problems being faced by Canada. "It's not going to be cheap," Roger Girard, Ontario's chief e-health strategist told Canadian Health Technology in reference to Ontario's efforts. He added that the province Ontario, which performs around 16.6 million diagnostic imaging exams annually, currently lacks the required funds to build an interoperable PACS network but that recommendations will be made to the government at a later date. Organisations and initiatives, such as Canada Health Infoway and Integrating the Healthcare Enterprise (IHE), which help systems to overcome systemic problems, are used to ensure that best standards are obtained for systems throughout the world. Interoperability is thought to improve healthcare services productivity by 25-35%.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.